$CTXR I’m curious, am I alone here in letting this play out past the ph 3 results and into the fda approval then beyond ? Why’s everyone talking about entry and exit points now ? The short term tax liabilities don’t seem worth it on a stock with this much potential - besides I don’t care how good you think you are at timing things it usually never plays out the way you had imagined. Stay long be strong and make some serious paper down the road. At least that’s my game plan 🤷🏻‍♂️
8
5
5 Likes